The QualityStocks Daily Friday, May 29th, 2020

Today's Top 3 Investment Newsletters

SmallCapRelations (SNOA) +79.30%

QualityStocks (HGEN) +65.00%

MarketClub Analysis (GMBL) +63.28%

The QualityStocks Daily Stock List

AdaptHealth Corp. (AHCOW)

PredictWallStreet, All Penny Stocks, Morningstar, OTC Markets, Market Chameleon, InvestingNote, Smart Business Dealmakers, NasdaqTrader, AcroFan, Wallet Investor, Stock Target Advisor, EOD Data, BioPortfolio, Wallmine, Seeking Alpha, wallstreet-online, last10k, Global Banking and Finance, Street Insider, TradingView, and Dividend Investor reported beforehand on AdaptHealth Corp. (AHCOW), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AdaptHealth Corp. is the third largest home medical equipment (HME) provider in the United States. The Company provides a family of medical products and solutions for rental and sale designed to help patients manage chronic conditions in the home, adapt to life and thrive. AdaptHealth services beneficiaries of Medicare, Medicaid, as well as commercial insurance payors. The Company serves patients via its network of 187 locations. AdaptHealth is headquartered in Plymouth Meeting, Pennsylvania.

The Company’s product and services offerings include sleep therapy equipment (CPAP and BiPAP machines and supplies), respiratory equipment (including oxygen, invasive and non-invasive ventilation), mobility equipment, wheelchairs, walkers, and hospital beds. In addition, AdaptHealth provides custom bracing services, hospice-focused HME services, wound therapy, and nutritional HME services.

AdaptHealth partners with an extensive and highly-diversified network of referral sources. This includes acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. More than 800k patients are served each year by the Company. Furthermore, 7k orders are processed daily and AdaptHealth has more than 800 commercial insurance contracts.

In November of 2019, AdaptHealth announced that it entered into a definitive agreement to acquire the Patient Care Solutions (PCS) business from McKesson Corporation. At present, PCS provides wound care supplies, ostomy supplies, urological supplies, incontinence supplies, diabetic care supplies, and breast pumps directly to patients across the U.S.. Following the acquisition of PCS in January 2020, AdaptHealth services greater than 1.4 million patients annually in all 50 States.

AdaptHealth announced in March 2020 that it acquired Healthline Medical Equipment, Inc. Healthline is a Texas-based provider of home medical equipment. AdaptHealth also announced the completion of the earlier announced acquisition of Advanced Home Care, Inc. Advanced operates 23 branch locations in Georgia, North Carolina, South Carolina, Tennessee, and Virginia.

This week, AdaptHealth announced that it entered into two separate definitive agreements to acquire San Diego, California based Solara Medical Supplies, LLC and Minneapolis, Minnesota based ActivStyle, Inc. Solara is the largest independent distributor of continuous glucose monitors (CGM) in the U.S. Solara offers a comprehensive suite of direct-to-patient diabetes management supplies to patients across the country, including CGMs, insulin pumps, as well as other diabetic supplies.

ActivStyle is a foremost direct-to-consumer supply company. It provides incontinence and urology products to patients throughout the U.S. ActivStyle presently serves patients in 48 states with a considerable presence in Illinois, Minnesota, Iowa, Ohio, Pennsylvania, Florida, and Texas.

AdaptHealth is scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020 at 3:30 p.m. Eastern Time. A live webcast of the presentation and replay will be available on the "Upcoming Events and Presentation" page of the Investors section of the Company's website at www.adapthealth.com.

AdaptHealth Corp. (AHCOW), closed Friday's trading session at $4.80, off by 4.00%, on 3,100 volume with 11 trades. The average volume for the last 3 months is 33,662 and the stock's 52-week low/high is $1.04499995/$6.3499999.

chart

Birchcliff Energy Ltd. (BIREF)

Energy Now, OilandGas360, Top Stocks News, GuruFocus, Proactive Investors, ShareCast, Market Screener, Simply Wall St, Preferred Stock Channel, Barchart, GlobeNewswire, Seeking Alpha, Stockhouse, TradingView, MarketBeat, Stockwatch, Business Insider, and Canadian Insider reported previously on Birchcliff Energy Ltd. (BIREF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Birchcliff Energy Ltd. explores for, develops, and produces natural gas, crude oil, and natural gas liquids in Western Canada. An intermediate oil and natural gas company, it has operations concentrated within its one core area, The Peace River Arch Of Alberta. Birchcliff has substantial in-house technical expertise and experience on the Peace River Arch. Established in 2004, Birchcliff Energy is headquartered in Calgary, Alberta. The Company lists on the OTC Markets.

Birchcliff Energy has focused assets in the Peace River Arch Area of Alberta on the Montney/Doig Resource Play. It essentially has a 100 percent Working Interest (WI); 99 percent of production is operated. The Company has a large, contiguous undeveloped land base with an average 89 percent WI.

Birchcliff Energy has significant control of infrastructure. This includes the 100 percent owned and operated 340 MMcf/d Pouce Coupe Gas Plant (PC Gas Plant). Furthermore, Birchcliff has a low decline production base (estimated 20 percent in 2019), and a top tier cost structure driving peer leading profitability.

The Company’s key strategic attributes include 18 gross (15.1 net) Montney sections contiguous to existing BIR infrastructure. There is the potential for 4 Montney intervals (Montney D1, D2, C, Basal Doig/Upper Montney).

This month, Birchcliff Energy announced its financial and operational results for the three months ended March 31, 2020 and the confirmation of the borrowing base limit under its credit facilities at $1.0 billion. The Company realized Quarterly Average Production of 73,580 boe/d in Q1 2020. This represents a 2 percent decrease from Q1 2019. Liquids accounted for roughly 22 percent of Birchcliff’s total production in Q1 2020 versus roughly 21 percent in Q1 2019.

Mr. Jeff Tonken, President and Chief Executive Officer of Birchcliff Energy, said, “Our industry is facing unprecedented challenges as a result of the impacts from the global COVID-19 pandemic which has resulted in a significant reduction in worldwide oil demand. We believe that Birchcliff’s strong financial position, low operating cost structure and low-decline asset base provides us with the ability to withstand these challenges. In addition, the reduced demand for oil has resulted in massive capital spending reductions and shut-ins of oil and natural gas production, leading to the strengthening of current and future natural gas prices in North America, which is key for our current and future adjusted funds flow.”

Birchcliff Energy Ltd. (BIREF), closed Friday's trading session at $1.0035, off by 3.5096%, on 49,917 volume with 6 trades. The average volume for the last 3 months is 121,737 and the stock's 52-week low/high is $0.398600012/$2.35688996.

chart
n

Diversicare Healthcare Services, Inc. (DVCR)

Buy Stocks Easy, Zacks, StockInvest.us, GuruFocus, 4-Traders, Morningstar, Dividend.com, Wall Street Analyzer, CSI Market, Street Insider, Stock Twits, thepharmaletter, last10k, Economies.com, Infront Analytics, Investing.com, Macrotrends, Stockopedia, The Stock Market Watch, TMXmoney, Morningstar, Dividend Channel, Market Screener, CRWEWorld, Nasdaq, EIN Presswire, TradingView, Simply Wall St, Stockhouse, Market Exclusive, and GlobeNewswire reported earlier on Diversicare Healthcare Services, Inc. (DVCR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Diversicare Healthcare Services, Inc. provides long-term care services to patients in 62 skilled nursing and senior housing centers containing 7,329 licensed nursing beds (as of December 31, 2019). The Company offers Short Stay Rehabilitation, Complex Medical Care, Long Term Care, Memory Care, Hospice Care, and Assisted Living. Diversicare has recognition as a premier provider of post-acute care. It has a comprehensive team trained to administer high quality healthcare that meets patients needs.

Established in 1994, Diversicare Healthcare Services has its corporate headquarters in Brentwood, Tennessee. The Company was previously known as Advocat, Inc. It changed its name to Diversicare Healthcare Services, Inc. in March of 2013. The Company’s shares trade on the OTC Markets’ OTCQX.

Diversicare Healthcare Services created and provides therapy powered by Diversicare Therapy Services (DTS). Its services incorporate up-to-date, evidence-based approaches to quality care and treatment in a safe environment. Diversicare Therapy Services’ (DTS’) team of therapists create customized rehabilitation programs based on an individual’s needs.

Diversicare’s physical, occupational, and speech-language pathologists specialize in innovative therapeutic approaches that center on achieving an individual’s best outcomes. In many centers, DTS offers outpatient services provided by the same therapists that assisted one in getting home. DTS has a team of more than 1,100 therapists.

This month, Diversicare Healthcare Services announced its results for Q1 ended March 31, 2020. Net Loss from Continuing Operations was $0.5 million, or $0.08 per share, in Q1 of 2020, versus a Net Loss from Continuing Operations of $1.6 million, or $0.24 per share, in Q1 of 2019. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter was $3.1 million. This was $2.0 million higher than Q1 of 2019 and $0.5 million higher than the preceding quarter.

Mr. Jay McKnight, President and Chief Executive Officer, of Diversicare Healthcare Services, said, "The first quarter started off well for Diversicare. January 2020 was one of the best months we have had in years. Unfortunately, we started seeing a decline in total patients served in the middle of February and that decline continued through the rest of the quarter and even through April. Despite the impact of the COVID-19 crisis that grew during the quarter, our results for the quarter are the best that we have reported for some time.”

Diversicare Healthcare Services, Inc. (DVCR), closed Friday's trading session at $1.15, off by 13.5338%, on 5,187 volume with 17 trades. The average volume for the last 3 months is 1,633 and the stock's 52-week low/high is $1.00/$2.99.

chart

LexaGene Holdings, Inc. (LXXGF)

NetworkNewsWire, Stock Day Media, Proactive Investors, OTC Markets, Wallet Investor, YCharts, Market Screener, Stockwatch, GlobeNewswire, Investor Ideas, InvestorsHub, Seeking Alpha, Morningstar, Value Forum, Dividend Investor, Metals News, GuruFocus, Macroaxis, Barchart, and Stockhouse reported earlier on LexaGene Holdings, Inc. (LXXGF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LexaGene Holdings, Inc. is a biotechnology company listed on the OTC Markets Group’s OTCQB. It develops genetic analyzers for rapid pathogen detection and other molecular markers. This is for on-site rapid testing in veterinary diagnostics, food safety, and for use in open-access markets such as clinical research, agricultural testing, and biodefense. Incorporated in 2007, LexaGene is based in Beverly, Massachusetts.

The LX Genetic Analyzer delivers first-rate sensitivity, specificity, and breadth of detection. It can return results in approximately 1 hour. End-users just need to collect a sample, load it onto the instrument with a sample preparation cartridge, enter sample ID, and press ‘go’. The design of the unique open-access feature is for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

The LX Genetic Analyzer is being designed for syndromic testing in veterinary diagnostics and human clinical diagnostics, and also food safety testing, water quality monitoring, and other markets that require critical answers in less time. It electronically records data for interfacing with food safety records or medical records and for easy retrieval of historical data (trends). It can test for up to 27 pathogens at once per test. The design of LexaGene’s technology is to be operated by the individuals collecting the samples; no pipetting or molecular expertise is required.

Last month, LexaGene announced the filing of a provisional patent application to the United States Patent and Trademark Office (USPTO) to protect the expanded testing capabilities of their LX Analyzer technology, as it relates to COVID-19 and other clinical laboratory testing, and also other high-throughput applications such as food safety testing. The Company plans to launch its multiplex, PCR-based LX Analyzer as its flagship product, targeting decentralized testing facilities in the clinical, veterinary, and food safety markets during Q3 of this year.

Yesterday, LexaGene announced the placing of a pre-commercial instrument that tests for COVID-19 and other respiratory pathogens at the Dartmouth-Hitchcock Medical Center (DHMC) in their Laboratory for Clinical Genomics and Advanced Technology (CGAT) in Hanover, New Hampshire.

Dr. Jack Regan, LexaGene’s Founder and Chief Executive Officer, stated, “We are excited to be able to contribute to the fight against COVID-19 and illustrate our applications in the human clinical space. Unlike many of the near-patient testing solutions used today that only look for COVID-19 and have a significant false negative rate, the instrument we have placed at Dartmouth-Hitchcock screens for many pathogens at once, namely COVID-19, influenza, RSV, adenovirus, metapneumovirus, and seasonal coronavirus, and it performs gold-standard chemistry for exceptional data quality.”

LexaGene Holdings, Inc. (LXXGF), closed Friday's trading session at $0.62, up 2.4793%, on 803,466 volume with 358 trades. The average volume for the last 3 months is 255,365 and the stock's 52-week low/high is $0.303799986/$0.75537002.

chart

OMNIQ Corp. (OMQS)

Wolf Street, Stock Day Media, Grocery Retail Online, CEORoadShow, OTC Markets, TipRanks, Market Screener, InvestorsHub, Wallet Investor, TeleTrader, GlobeNewswire, Stockhouse, Street Insider, Ceo.ca, GuruFocus, Central Charts, OTCre.com, TradingView, Simply Wall St, Validea, Seeking Alpha, Emerging Growth, Barchart, Investing.com, Morningstar, Nasdaq, Stockopedia, Dividend Investor, Dividend.com, and last10k reported previously on OMNIQ Corp. (OMQS), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OMNIQ Corp. provides computerized and machine vision image processing solutions that use patented and proprietary AI (Artificial Intelligence) technology to deliver data collection, real time surveillance and monitoring. These are for supply chain management, homeland security, public safety, traffic & parking management, and access control applications. At present, the Company addresses several billion-dollar markets. These include the Global Safe City market, forecast to grow to $29 billion by 2022, and the Ticketless Safe Parking market, forecast to grow to $5.2 billion by 2023. The OTCQB-listed Company previously went by the name Quest Solution, Inc. It changed its name to OMNIQ Corp. in November of 2019. The Company is based in Salt Lake City, Utah.

Fundamentally, OMNIQ is a specialty systems integrator with an emphasis on the design, delivery, deployment, and support of field service and supply chain mobility solutions throughout the U.S. It takes a consultative approach through offering end-to-end solutions that include hardware, software, communications, and full lifecycle management services.

In addition, the Company is an established manufacturer and distributor of barcode labels, tags, and ribbons, and also RFID (radio-frequency identification) labels and tags. OMNIQ offers comprehensive packaged and configurable software and is a foremost provider of best-in-class mobile and wireless equipment.

OMNIQ’s customers include government agencies and top Fortune 500 companies from a number of sectors. These include manufacturing, retail, distribution, food and beverage, transportation and logistics, healthcare, and oil, gas, and chemicals. The technology and services provided by OMNIQ help clients move people, assets, and data safely and securely through airports, warehouses, schools, national borders, and many other applications and environments.

Recently, OMNIQ announced it received a purchase order valued at over $3.9 million from one of the largest U.S. supermarket chains for the supply of mobile data collection, computing, and communications equipment. This order represents follow-on business from this customer, who recently purchased $1.5 million in handheld equipment from OMNIQ.

During and after the close of Q1 of 2020, OMNIQ introduced the SeeTire™ solution for tire identification, facilitating more efficient inventory management and collection of point of sales data; and also acquired the IP (Intellectual Property) and certain other assets of Eyepax USA. Eyepax is a provider of customizable software and hardware packages for cloud-based parking management solutions. OMNIQ also filed a patent for the SeeHOV™ solution for High Occupancy Vehicle (HOV) detection and enforcement.

Last week, OMNIQ announced that it was awarded a key project by the city of San Mateo, California to provide a unique cloud-based Smart City parking and traffic control solution. The basis of this system is on OMNIQ’s AI-Machine Vision technology integrated with its recently acquired PERCS™ solution, which will assist in keeping the streets of San Mateo safe, secure, and congestion-free by automating the enforcement and citation of traffic and parking regulations on city streets.

OMNIQ Corp. (OMQS), closed Friday's trading session at $6.25, up 4.1667%, on 2,629 volume with 18 trades. The average volume for the last 3 months is 1,413 and the stock's 52-week low/high is $2.50/$9.60000038.

chart

Quantum Computing, Inc. (QUBT)

Proactive Investors, Tip Ranks, CSI Market, OTC Markets, Investor Place, last10k, GlobeNewswire, Market Wire News, InvestorsHub, Stockopedia, Dividend Investor, GuruFocus, Wallet Investor, Stockhouse, Morningstar, Simply Wall St, and YCharts reported beforehand on Quantum Computing, Inc. (QUBT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Quantum Computing, Inc. is a technology company based in Leesburg Virginia. It focuses on developing novel applications and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. The Company was formerly known as Innovative Beverage Group Holdings, Inc. Quantum Computing lists on the OTC Markets’ OTCQB.

The Company has put together a world-class team of experts in supercomputing, technology, defense, and government. This team is working to develop solutions to world-class problems. It is developing processes to commercialize advances in quantum computing.

Quantum Computing is leveraging its collective expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial and security sectors. It is developing a variety of software applications capable of running on quantum and quantum-inspired hardware from numerous vendors. The Company’s initial emphasis is on the creation of Quantum Finance applications.

Mukai is Quantum Computing’s proprietary middleware environment for developing applications to address complex optimization problems that are NP-hard, often involving multi-dimensional solution spaces with thousands if not hundreds of thousands of variables. The software stack contained in Mukai enables developers to create and deploy applications with superior performance on classical computers and future quantum computers.

Regarding Quantum Asset Allocator, Fund Managers can now use the Company’s quantum asset allocator to take advantage of quantum-inspired techniques to solve the NP-hard problems preventing them from truly optimal portfolio optimization. Concerning Community Detection, the Quantum Community Detector utilizes advanced graph analytics with quantum-inspired techniques to deliver insights into big data structures.

Last month, Quantum Computing announced the release of version 1.1 of its Mukai middleware with new capabilities delivering higher performance and greater ease of use for subject-matter experts developing quantum-ready applications needing superior performance. The Mukai software stack (released in January of 2020) can be used to solve extremely complex optimization problems.

Last week, Quantum Computing announced it appointed noted IT (Information Technology) expert and industry thought leader, Mr. Majed Saadi, to serve on its Technical Advisory Board. Mr. Saadi brings to Quantum Computing greater than 20 years of executive leadership and experience in strategy development and IT transformation, and also functional knowledge in the domains of cloud computing, platform development, enterprise architecture, and enterprise systems management.

Quantum Computing, Inc. (QUBT), closed Friday's trading session at $2.05, up 28.125%, on 87,090 volume with 250 trades. The average volume for the last 3 months is 17,742 and the stock's 52-week low/high is $0.779999971/$7.50.

chart

Smith-Midland Corporation (SMID)

ValueWalk, TradingView, Zacks, GEO Investing, TipRanks, Market Screener, StockInvest.us, Wallet Investor, Nasdaq, GlobeNewswire, Simply Wall St, MarketBeat, Funding Universe, Stockhouse, InvestorsHub, Tech Capital, Investing.com, 4-Traders, Wallet Investor, Corporate Information, GuruFocus, Business Wire, last10k, Stockopedia, Value Walk, Baystreet.ca, and TMXmoney reported previously on Smith-Midland Corporation (SMID), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Smith-Midland Corporation develops, manufactures, and sells a broad array of precast concrete products for use primarily in the construction, transportation, and utilities industries. The OTCQX-listed Company has three manufacturing facilities located in Midland, Virginia; Reidsville, North Carolina; and Columbia, South Carolina. Formed in 1960, Smith-Midland has its corporate office in Midland, Virginia.

Easi-Set Worldwide is a wholly-owned subsidiary of Smith-Midland Corporation. Easi-Set Worldwide licenses the production and sale of Easi-Set products, including J-J Hooks, and provides diversification opportunities to the precast industry around the world.

In addition, Concrete Safety Systems (CSS) is Smith-Midland’s safety barrier rental division. CSS is supplied by Smith-Midland’s three production facilities. CSS provides concrete safety barrier rental for highway construction and other projects across its mid-Atlantic and Southeast market area. CSS serves its regional clients through a network of seven rental yards.

Smith-Midland’s manufacturing plants include steel shops, form fabrication shops, automated concrete batch plants, and environmentally controlled casting areas. Among the Company’s major innovations are J-J Hooks positive connection safety barriers; SoftSound, a sound absorbing concrete for highway sound barrier; and Easi-Set/Easi-Span Precast Buildings with post-tensioned roofs & floors. Additionally, major innovations include SlenderWall architectural building panels and Beach Prisms Shoreline erosion control product.

J-J Hooks is the most popular barrier connection design in North America. It continues to play a leadership role in safety innovation for the highway construction industry. More than 15,000,000 linear feet of J-J Hooks temporary barrier have been produced and installed worldwide since its introduction in 1990.

Smith-Midland's new North Carolina precast concrete plant, Smith-Carolina, has opened for business. The 15,000 square foot enclosed plant sits on a 46 acre yard at 654 Freeway Drive in Reidsville, North Carolina. New features include a large capacity 4-yard concrete batch plant, and two 20-ton overhead bridge cranes. Initial production started on high-demand products such as the market leading J-J Hooks precast concrete highway barrier.

This month, Smith-Midland announced results for the quarter ended March 31, 2020. It reported Q1 Revenues of $9.8 million for 2020 and $10.2 million for the comparable quarter of 2019. This represents a decrease of $0.4 million, or 4 percent.

The Pre-Tax Loss for Q1 of 2020 was $0.1 million versus Pre-Tax Income of $0.4 million in 2019. This represents a decrease of $0.5 million. The Company had a Net Loss for Q1 of 2020 of $0.1 million versus Net Income of $0.3 million in 2019. This represents a decrease of $0.4 million. The Basic and Diluted Loss per Share was $0.01 for Q1 2020, while the Basic and Diluted Income per Share was $0.06 for Q1 2019.

Smith-Midland Corporation (SMID), closed Friday's trading session at $4.80, up 1.0526%, on 4,160 volume with 14 trades. The average volume for the last 3 months is 3,800 and the stock's 52-week low/high is $2.95000004/$9.52999973.

chart

Sonoma Pharmaceuticals, Inc. (SNOA)

Zacks, Stock Twits, Market Chameleon, Stock Split History, Whale Wisdom, last10k, Morningstar, Nasdaq, GuruFocus, Simply Wall St, InvestorsHub, Invest Chronicle, StockInvest.us, Stockopedia, Macrotrends, Dividend Investor, Market Exclusive, Street Insider, ChartMill, and GlobeNewswire reported beforehand on Sonoma Pharmaceuticals, Inc. (SNOA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Petaluma, California. It develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. The Company’s products sell across the United States and internationally. The Company formerly went by the name Oculus Innovative Sciences, Inc. It changed its corporate name to Sonoma Pharmaceuticals, Inc. in December of 2016.

Sonoma Pharmaceuticals has manufacturing operations in the USA and Latin America. Its European marketing and sales are based in Roermond, Netherlands. The Company lists on the NasdaqCM.

Sonoma Pharmaceuticals’ products have improved outcomes for more than six million patients worldwide through decreasing infections, itch, pain, scarring, and harmful inflammatory responses. The Company is the global leader in Hypochlorous Acid (HOCl) based health care solutions.

Sonoma began with HOCl based products for wound care patients. After much success helping millions of patients, it has since expanded into dermatology, eye care, as well as animal health.

Sonoma Pharmaceuticals has pioneered the use of HOCl in the specialty pharmaceutical sector. The Company develops safe and effective healthcare solutions. Its main focus is developing inventive solutions for dermatological conditions, eye care, and also advanced tissue care.

This past January, Sonoma Pharmaceuticals announced that it began a process to explore and evaluate strategic alternatives for its U.S. Dermatology Division. The Company has engaged Maxim Group LLC as its financial advisor to assist in the process.

Recently, Sonoma Pharmaceuticals announced that it successfully closed on an asset purchase agreement for certain wound care, disinfection, and animal health care products in the Middle East, Australia and Europe for $1.1 million with MicroSafe Group. The Company’s long-term partnership with MicroSafe in the Middle East has led to the successful growth of sales of Microcyn® Technology products in the region.

Sonoma Pharmaceuticals’ innovative and versatile Microcyn® Technology has been broadly used for wound cleansing and irrigation, and also a disinfectant for surfaces, including in Mecca during the Hajj season, to lessen the risk of transmission of infectious diseases. The MicroSafe Group has operations in a number of countries with its head office in Dubai, United Arab Emirates (UAE).

Sonoma Pharmaceuticals, Inc. (SNOA), closed Friday's trading session at $9.70, up 79.2976%, on 34,597,168 volume with 214,350 trades. The average volume for the last 3 months is 31,138 and the stock's 52-week low/high is $3.32999992/$19.6000003.

chart

Humanigen, Inc. (HGEN)

NetworkNewsWire, Proactive Investors, 4-Traders, Trading View, Stockhouse, StreetWise Reports, Street Insider, Wall Street Analyzer, Investors Hangout, StockInvest.us, Whale Wisdom, TipRanks, Proactive Investors, Stockopedia, GlobeNewswire, InvestorsHub, Dividend Investor, Insider Financial, Morningstar, Equity Clock, and Barchart reported previously on Humanigen, Inc. (HGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Humanigen, Inc. is developing its Humaneered® proprietary monoclonal antibodies to address critical unmet needs in today's most advanced cancer therapies. A biopharmaceutical Company, it is developing its portfolio of Humaneered® monoclonal antibodies centered on CAR-T optimization and immuno-oncology. Humaneering is a patented proprietary technology for converting suboptimal antibodies into human antibodies suitable for chronic therapies, in part, because of low immunogenicity.

The Company previously went by the name KaloBios Pharmaceuticals, Inc. It changed its name to Humanigen, Inc. in August of 2017. Humanigen is headquartered in Burlingame, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Originated from Humanigen’s Humaneered® platform, lenzilumab and ifabotuzumab, and HGEN005 are monoclonal antibodies with first-in-class mechanisms. Lenzilumab targets GM-CSF. It is in development as a potential biologic therapy to make CAR-T therapy safer and more effective, and also a potential treatment for hematologic cancers. Ifabotuzumab targets the Eph type-A receptor 3 (EphA3). It is being explored as a potential treatment for glioblastoma multiforme (GBM) and a range of solid tumors, as an optimized naked antibody and as part of an antibody-drug conjugate, as well as a backbone for a novel CAR-T construct, and a bispecific antibody platform.

HGEN005 selectively targets the eosinophil receptor EMR1. It is being explored as a potential treatment for a range of eosinophilic diseases. This includes eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct.

Last week, Humanigen announced that the FDA (Food and Drug Administration) approved the administration of lenzilumab for COVID-19 patients under individual patient emergency IND applications to patients under Humanigen’s compassionate use program. Humanigen is advancing plans to conduct a multicenter, Phase III, randomized, double-blinded, controlled, clinical trial with lenzilumab for the prevention of ARDS and/or death in hospitalized patients with pneumonia associated with coronavirus 2 (SARS-CoV-2) infection in COVID-19 patients.

Dr. Cameron Durrant, Chief Executive Officer of Humanigen, said, "We are gratified to be able to offer compassionate use of lenzilumab for patients with COVID-19. Humanigen has pioneered the field of GM-CSF neutralization and, unlike other GM-CSF approaches, has already conducted two Phase I and two Phase II studies, including in patients with severe respiratory conditions, with excellent safety results."

Humanigen, Inc. (HGEN), closed Friday's trading session at $1.485, up 65.00%, on 277,312 volume with 314 trades. The average volume for the last 3 months is 68,446 and the stock's 52-week low/high is $0.300000011/$2.03999996.

chart

Meso Numismatics, Inc. (MSSV)

RedChip, OTC Dynamics, TeleTrader, Last10k, TipRanks, Street Insider, Nasdaq, Simply Wall St, Investing.com, Financial Buzz, Dividend Investor, Otc.watch, InvestorsHub, MarketWatch, Stockwatch, Investors Hangout, GlobeNewswire, New Media Wire, Stockhouse, Wallet Investor, and TradingView reported earlier on Meso Numismatics, Inc. (MSSV), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Meso Numismatics, Inc. is a technology and numismatic company specializing in the Meso Region, including Central America and the Caribbean. It has become the primary hub for rare, exquisite, and valuable inventory from the Meso Region and worldwide. The Company was previously known as Pure Hospitality Solutions, Inc. It changed its name to Meso Numismatics, Inc. as a result of its merger with Meso Numismatics, Corp. in September of 2018. Meso Numismatics has its head office in Boca Raton, Florida.

Meso Numismatics is the only Company in the Central American-Caribbean region that is an on-the-ground registered dealer with the Numismatic Guaranty Company (NGC) and the Paper Money Guaranty (PMG). The Company has a selection of rare inventory, and also has a specialized App for banknote recognition, available on Google Play and the Apple App Store. Meso continues to partner with some of the largest auction houses internationally for the sale of the Company’s rarer inventory.

Meso Numismatics was established in September 2016 by a group of devoted coin collectors and currency seekers from the Mesoamerica area - from Mexico to Panama. The Company specializes in this area of the region. Moreover, Meso also has inventory and clients from all over the world. Numismatics is the study or collection of currency. This includes coins, tokens, paper money, as well as related objects.

In September, Meso Numismatics announced that it has preliminarily completed the due diligence phase of the Green Pay acquisition and is now set to proceed with an audit of Green Pay to be performed by the Company’s independent registered accounting firm. According to Management, Meso’s counsel will soon begin preparing the definitive purchase agreement for the Green Pay acquisition.

Afterward, the expectation is that Meso Numismatics will issue shares of its Preferred Stock as an initial payment for the acquisition. Following that, its U.S. independent registered accounting firm will start to audit Green Pay’s financials, preparing them to be included in Meso’s SEC filings at some later date.

At present, Green Pay hosts 110 independent stores located around Central America; processes around $2.5M in monthly transactions among all of its users; and executes roughly 500,000 transactions per month. Green Pay also has approximately 400,000 monthly active users; and has about 650,000 registered credit cards representing multiple payment institutions around Central America.

Meso Numismatics, Inc. (MSSV), closed Friday's trading session at $0.0169, up 85.7143%, on 11,379 volume with 4 trades. The average volume for the last 3 months is 18,262 and the stock's 52-week low/high is $0.007199999/$0.148499995.

chart

GlyEco, Inc. (GLYE)

Stockpools, Zacks, Stockwatch, Alternative Energy Stocks, GuruFocus, The Street, MarketWatch, Simply Wall St, Stockhouse, Equity Clock, Market Screener, Barchart, Equities, Real Investment Advice, Last10k, Wallet Investor, Accesswire, Seeking Alpha, Marketbeat, Dividend Investor, and InvestorsHub reported earlier on GlyEco, Inc. (GLYE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A chemical company, GlyEco, Inc. focuses on technology development and the manufacturing of coolants, additives, as well as related performance fluids. The Company specializes in coolants, additives, and related performance fluids, which protect equipment that needs to work hard. This includes on-road engines, and stationary engines to fluid containing systems and other equipment that uses glycol-based fluids. GlyEco has its corporate office in Institute, West Virginia. The Company lists on the OTC Markets.

GlyEco serves and supports the automotive, heavy-duty, and industrial markets and its speciality is chemical manufacturing. GlyEco’s Institute, West Virginia distillation facility produces antifreeze grade and industrial grade mono-ethylene glycol.

GlyEco acquired WEBA Technology Corp. in December of 2016. Since 2002, WEBA has been producing inhibitors for water/glycol solutions. WEBA manufactures METALGUARD additives. These are concentrated inhibitor packages to protect numerous metal types in diverse applications.

WEBA Technology product lines include METALGUARD Extended life additives (OAT, HOAT, NOAT, P-OAT, S-OAT); METALGUARD Conventional additives (light and heavy-duty); METALGUARD Heat transfer fluid additives; and Specialty and Custom inhibitors.

GlyEco offers an array of antifreeze products. These include Light-Duty Extended Life; Universal Extended Life Antifreeze; Poly-Organic Extended Life Antifreeze; Heavy-Duty Conventional Antifreeze; and OAT Heavy-Duty Extended Life Antifreeze.

Recently, GlyEco announced financial results for the full year ended December 31, 2018. The Company completed the sale of its assets related to its consumer segment effective January 11, 2019. Full Year 2018 highlights include Net Revenues of $6.5 million. This is up 11 percent versus $5.8 million for Full-Year 2017.

Total Gross Profit was $1,285,000, or 20 percent of Revenues, versus $885,000, or 15 percent of Revenues for 2017. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), a non-GAAP measure, was $(1,565,000) versus $(2,331,000) for 2017. GlyEco reported a Net Loss of $3,452,000 for 2018, versus a Net Loss of $5,078,000 for 2017.

GlyEco, Inc. (GLYE), closed Friday's trading session at $0.30395, up 406.5833%, on 300 volume with 1 trade. The average volume for the last 3 months is 1,117 and the stock's 52-week low/high is $0.030549999/$2.00.

chart

Stealth Technologies, Inc. (STTH)

NetworkNewsWire and RedChip reported previously on Stealth Technologies, Inc. (STTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stealth Technologies, Inc. is a technology business listed on the OTC Markets Group’s OTCQB. The Company previously went by the name Excelsis Investments, Inc. It changed its name to Stealth Technologies, Inc. in July 2016. Stealth Technologies engages in identifying and capitalizing on technology and associated markets. The Company produces products for personal and financial protection.

Incorporated in 2010, Stealth Technologies has its corporate office in Largo, Florida. It became public through a reverse merger in 2012.

Moreover, Stealth Technologies announced in March of this year the completion of five new products. Currently, these products are staged in a large direct response retailer's quality assurance and legal department. They are under final review to ensure that marketing claims associated with each product are accurate when measured against actual performance levels of each product, and that assurance and inventory is satisfactory and has met all quality control factors. Stealth Technologies’ strategic initiative is to expand its product footprint across varied industries and distributors.

The Company has developed a group of products to protect against "electronic pickpockets," emergency response latency, credit fraud protection, and cell phone data protection. Its initial product to market is the Stealth Card.

The design of the Stealth Card is to protect the Radio-Frequency Identification (RFID) chip in a consumer's credit card from electronic stealing or pickpocketing, which uses a smartphone, credit card reader, or RFID antenna to remotely access data stored on the consumer's Smartchip. Stealth Card renders the chipped information invisible to intrusion.

The Stealth Card is a 100 percent USA product. The Stealth Card is manufactured from Stealth Technologies’ laboratory and research/development facility in West Virginia to its manufacturing facility in Massachusetts.

Development for the Stealth Card started in 2012. This is when Company Founder and Chief Executive Officer (CEO), President, and Director, Mr. Brian McFadden, observed the worldwide shift towards smart chip card technology to transmit and process credit card/debit card transactions. With Europe and Asia already making the transition away from the magnetic strip to smart chip cards, Mr. McFadden believed the United States market would need to follow suit.

To use the Stealth Card, a person places a Stealth Card in their wallet, pocket, change purse or anywhere they carry their credit cards. One card can protect up to 12 cards in a wallet. The card can be physically placed anywhere in a wallet or pocket.

The card does not need to be in the front or back of one’s wallet. The Stealth Card provides effective protection irrespective of where it’s placed in relation to one’s credit cards.

In December 2016, Stealth Technologies announced the development of the 911 Help Now Generation II Product. The 911 Help Now product provides a direct two-way voice connection to emergency service providers. The 911 Help Now pendent works by pressing the Help Now button and then a person is connected.

Stealth Technologies has a number of other products under development. The Company is exploring potential military applications of its proprietary technologies.

Along with the Stealth Card and the 911 Help Now Generation II Product, Stealth Technologies’ portfolio includes Data Secure Plus, which is new to market. Its portfolio also includes Stealth Mobile.

Stealth Technologies, Inc. (STTH), closed Friday's trading session at $0.0197, up 74.3363%, on 6,100 volume with 2 trades. The average volume for the last 3 months is 3,377,043 and the stock's 52-week low/high is $0.009999999/$2.28999996.

chart

Vycor Medical, Inc. (VYCO)

PennyStockScholar, FeedBlitz, OTCtipReporter, and Wall Street Resources reported earlier on Vycor Medical, Inc. (VYCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Vycor Medical, Inc. is a provider of distinct and first-class surgical and therapeutic solutions. The Company operates two business units - Vycor Medical and NovaVision. Both of these business units adopt a minimally or non-invasive approach. Vycor Medical has U.S. Food and Drug Administration (FDA) 510(k) clearance for brain and spine surgeries and regulatory approvals for brain in Australia, Brazil, Canada, China, Europe (EU – Class III), Korea, Japan, Russia, and Taiwan. Vycor Medical is based in Boca Raton, Florida.

The Company’s NovaVision provides non-invasive, computer-based rehabilitation targeted at a substantial and largely un-addressed market of people who have lost their sight because of stroke or brain injury. The NovaVision business unit develops and provides science-driven neurostimulation therapy and other medical technologies. This helps improve and partially restore sight in patients with neurological vision impairments.

Vycor Medical’s ViewSite™ Surgical Access Systems (VBAS) is a suite of clear cylindrical minimally invasive disposable devices. These have the potential for quicker, safer, and also more economical brain surgeries, as well as faster patient discharge.

The design of VBAS is to optimize neurosurgical site access and reduce patient risk. In addition, the design of VBAS is to expedite recovery and add tangible value to the professional medical community.

The Company’s proprietary Visual Restoration Therapy® (VRT) platform is clinically supported to improve lost vision resulting from stroke, traumatic brain injury (TBI), or other acquired brain injuries. VRT is the only FDA 510K cleared medical device in the United States targeted at the restoration of vision for neurologically induced vision loss.

Vycor Medical has developed NeuroEyeCoach™. This is a therapy that is highly complementary to VRT™. NeuroEyeCoach™ is a compensation therapy registered in the United States as a Class I 510(k) exempt device. The design of NeuroEyeCoach is to improve a patient's ability to scan their environment more efficiently. NeuroEyeCoach is NovaVision's eye movement compensation therapy for patients who have suffered a cerebral visual field disorder due to a stroke or brain injury.

In August, Vycor Medical reported financial results for the three and six months ended June 30, 2017. The Company’s Revenues for the six months ended June 30, 2017 were $736,000 versus $779,000 for the same period the year prior. Cash Operating Loss was $235,000, versus $329,000 for the same period in 2016. This represents a reduction of 29 percent. Operating Loss was $654,000, versus $806,000. This represents a reduction of 19 percent.

During the period, the US patent office (USPTO) issued/allowed four patents. These are all directed to the integration of neuro-navigation systems with Vycor Medical's VBAS retractor system.

The patents complement and strengthen the Company’s existing patent portfolio. This is especially in relation to Vycor’s continuing emphasis to more fully integrate its VBAS product range with neuro-navigation systems without sacrificing the surgeon's ability to visually inspect the surrounding tissue as the devices undergo insertion.

Vycor Medical, Inc. (VYCO), closed Friday's trading session at $0.0994, up 90.7869%, on 86,158 volume with 39 trades. The average volume for the last 3 months is 14,232 and the stock's 52-week low/high is $0.0102/$0.50999999.

chart

North American Cannabis Holdings, Inc. (USMJ)

Wolf Street, Pink Investing, SmallCap Exclusive, Investor Ideas, PotStockNews, Micro Small Cap, hot Stocked, Real Investment Advice, Tech Stock Observer, Pitchbook, GuruFocus, Research Pool, Nasdaq, Stockhouse, Morningstar, Market Exclusive, Daily Marijuana Observer, Insider Financial, Seeking Alpha, BioSpace, Wallet Investor, InvestorsHub, Infront Analytics, GlobeNewswire, PR Newswire, Simply Wall St, and Dividend Investor reported earlier on North American Cannabis Holdings, Inc. (USMJ), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

North American Cannabis Holdings, Inc., through its subsidiaries, operates in the legal cannabis market in the U.S. The Company conducts various pilots in the legal cannabis sector so as to explore different high growth potential business opportunities. The Company previously went by the name Algae International Group, Inc. It changed its corporate name to North American Cannabis Holdings, Inc. in June of 2015. Headquartered in Texas, the Company lists on the OTC Markets.

Additionally, North American Cannabis operates a destination beverage company. It enables consumers to interface with staff to learn about the specific benefits of cannabis, and select healthy and refreshing cannabis infused beverages that include custom blended hemp infused coffee, cold pressed juices, and smoothies. Furthermore, the Company offers raw hemp seeds and other hemp infused foods.

North American Cannabis has a curated product line of legal cannabinoids and accessories. All of the Company’s products are lab-tested and contain no THC (tetrahydrocannabinol) through a carefully monitored extraction process. Its products are all natural, all safe, and also all CBD (cannabidiol). North American Cannabis carries numerous CBD and CBG Smokable products in Pre Roll and Flower. The Company has greater than 150 CBD, Hemp, and also Cannabis Essentials products available online.

Recently, North American Cannabis announced that CBD Products for Pets are now available on the Company's eCommerce site www.USMJ.com. NaturVet, Sun Valley, as well as NuLeaf supplements for cat and dog health and to help cats and dogs with different causes of discomfort are all now available online.

USMJ is a subsidiary company of North American Cannabis Holdings. USMJ partners with premier CBD producers. USMJ curates each product selection to work as promised and to ensure each item it sells is safe and effective. The Company notes that the www.USMJ.com brand name recognition is expanding strengthened by the brand recognition of the products available on the site.

North American Cannabis Holdings, Inc. (USMJ), closed Friday's trading session at $0.0002, up 100.00%, on 30,374,120 volume with 90 trades. The average volume for the last 3 months is 27,093,544 and the stock's 52-week low/high is $0.000099999/$0.0006.

chart

The QualityStocks Company Corner

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading provider of in-process, quality-assurance software for the additive manufacturing industry, recently appointed experienced software industry executive Mark K. Ruport as CEO and president (http://nnw.fm/p488B). The move finalizes the company’s management transition process. To view the full article, visit http://nnw.fm/woBz7

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Friday's trading session at $2.59, up 3.60%, on 1,044,858 volume with 3,404 trades. The average volume for the last 3 months is 471,896 and the stock's 52-week low/high is $1.97000002/$17.00.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX) recently announced the rebranding of its investor intelligence platform from SRAX IR to Sequire. To view the full article, visit http://nnw.fm/h4YqN

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $1.73, even for the day, on 25,928 volume with 116 trades. The average volume for the last 3 months is 57,354 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

chart

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), the largest producer of uranium and the leading conventional producer of vanadium in the United States, has announced that it has finalized agreements with Constantine Karayannopoulos and Brock O’Kelley, two rare earth element (REE) industry experts, to consult with the company in the development and implementation of commercial and technical REE strategies for the new U.S. REE program (http://nnw.fm/z82zF).

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Friday's trading session at $1.72, up 5.5215%, on 1,294,138 volume with 3,534 trades. The average volume for the last 3 months is 1,689,291 and the stock's 52-week low/high is $0.779999971/$3.31999993.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI) CEO Dr. Carl Schwartz recently referred to the company’s Helomics subsidiary as a “major asset” during an exclusive NNW interview with Stuart Smith (http://nnw.fm/54qVZ). An article discussing the interview reads, “During the interview, Schwartz pointed out that Helomics’ collection of more than 150,000 cancer tumors is the largest inventory of its kind in the world and that the impressive collection ‘was amassed over the last two decades by physicians sending in cancerous tumors to be tested with the known therapies of the time. To view the full article, visit http://nnw.fm/nSo5X

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Friday's trading session at $1.54, up 1.9868%, on 391,254 volume with 1,276 trades. The average volume for the last 3 months is 1,043,480 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

chart

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that certain shareholders have agreed to a voluntary resale restriction period covering 17,840,000 common shares extending the period of time before the shares become free trading to July 15, 2020. To view the full press release, visit http://cnw.fm/k8Hb7

Champignon Brands Inc. (FWB: 496) (CSE: SHRM) (OTC: SHRMF) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRMF), closed Friday's trading session at $1.34, up 7.5138%, on 596,426 volume with 745 trades. The average volume for the last 3 months is 603,134 and the stock's 52-week low/high is $0.221/$1.74.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. To view the full press releases, visit http://cnw.fm/VpO04 and http://cnw.fm/X4WPc.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.0054, up 2.8571%, on 5,450,299 volume with 102 trades. The average volume for the last 3 months is 5,363,793 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

Recent studies indicate that the restoration industry as a whole is worth an estimated $210 billion (http://nnw.fm/yV0OJ) and is expected to only increase in value with the increasing intensity and number of natural disasters. With experts predicting that the disaster recovery and restoration sector will only continue its upward trajectory, National Storm Recovery Inc. (OTC: NSRI) looks to be in an ideal position to ride the wave and benefit from the storm and disaster recovery solutions it provides.

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Friday's trading session at $0.35, even for the day, on 200 volume with 2 trades. The average volume for the last 3 months is 986 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis branded products company in the U.S., on Thursday released its unaudited financial and operational results for the three months ended March 31, 2020, expressed in U.S. dollars. Among other highlights, the company reported an increase in net revenues to $4.7 million in Q1 2020, representing a 46% year-over-year growth as compared to Q1 2019, as well as a 36% quarter-over-quarter growth as compared to Q4 2019. To view the full press release, visit http://cnw.fm/e54bE

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $0.67234, off by 8.8723%, on 61,661 volume with 68 trades. The average volume for the last 3 months is 36,751 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global (OTCQB: SHRG), a diversified holding corporation, recently reported that sales of Elevate MAX, a new featured beverage in its Elevacity nootropic product line, have exceeded the company’s expectations and surpassed all previous product launches. To view the full article, visit http://nnw.fm/MjO6x

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.071, off by 5.3333%, on 115,654 volume with 4 trades. The average volume for the last 3 months is 404,962 and the stock's 52-week low/high is $0.0215/$0.249799996.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD) was recently the subject of a report conducted by Global Small Cap Research (http://cnw.fm/W1a82). To view the full press release, visit http://cnw.fm/8jp5X. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. In the coming months, Oklahoma may be pioneering a pilot program that will greatly influence how driving laws are enforced in regard to cannabis use. The state is currently working on the implementation of a program to conduct marijuana breathalyzer tests which will allow the police to accurately determine who’s driving while high. Last week, Oklahoma’s legislature passed legislation requiring the Department of Public Safety to dedicate $300,000 to pay for the marijuana breathalyzer test kits. The agency will be tasked with coming up with new rules and regulations for the pilot program.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.0018, off by 5.2632%, on 22,250,594 volume with 162 trades. The average volume for the last 3 months is 25,305,502 and the stock's 52-week low/high is $0.001799999/$0.050500001.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and certain of its direct and indirect wholly owned subsidiaries (collectively “GGB”, the “Company” or the “Applicants”) today provided an update on its insolvency proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Friday's trading session at $0.0142, up 9.2308%, on 2,138,715 volume with 174 trades. The average volume for the last 3 months is 1,032,127 and the stock's 52-week low/high is $0.0092/$2.83999991.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives offering insights into various companies and their operations and future outlooks. Among other highlights, this week’s episode featured CEO Warren Wang as he confirmed revenue numbers and success of the company’s trading service on YouTube, as well as revealed plans for CBD Biotech. To view the full press release, visit http://cnw.fm/yOR06

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.0699, even for the day, on 12,200 volume with 5 trades. The average volume for the last 3 months is 58,408 and the stock's 52-week low/high is $0.059999998/$0.469999998.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) on Thursday announced the election of each of the seven individuals nominated as a director of VIVO at the company's Annual General and Special Meeting of Shareholders held on May 28, 2020. According to the update, VIVO management nominated each of the existing directors, together with new nominee, Christie Henderson, for election at the meeting. To view the full press release, visit http://cnw.fm/JR78t

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Friday's trading session at $0.1838, off by 3.314%, on 100,386 volume with 57 trades. The average volume for the last 3 months is 145,554 and the stock's 52-week low/high is $0.109999999/$0.524999976.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $2.36, off by 8.5271%, on 41,799 volume with 50 trades. The average volume for the last 3 months is 15,830 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.